Novartis Ag (NVSEF) Shares Outstanding (Weighted Average) (2009 - 2026)

Novartis Ag has disclosed Shares Outstanding (Weighted Average) across 16 years of filings, most recently posting $736.0 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $736.0 million, up 40218579134.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $736.0 million (up 40218579134.97% YoY), and the FY2025 annual result was $766.0 million, down 3.4% from the prior year.
• Shares Outstanding (Weighted Average) came in at $736.0 million for Q1 2026 at Novartis Ag, down from $766.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $2.1 billion in Q4 2022 to a low of $1.83 in Q1 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $825.0 million (2023), against an average of $940.7 million.
• Across the five-year window, Shares Outstanding (Weighted Average) sank 100.0% in 2025 and surged 40218579134.97% in 2026, its largest moves.
• Novartis Ag's Shares Outstanding (Weighted Average) stood at $2.1 billion in 2022, then fell by 2.01% to $2.1 billion in 2023, then plunged by 61.82% to $793.0 million in 2024, then dropped by 3.4% to $766.0 million in 2025, then slipped by 3.92% to $736.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $736.0 million (Q1 2026), $766.0 million (Q4 2025), and $766.0 million (Q3 2025), per Business Quant data.